Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Apraglutide and N-acetylcysteine (NAC) show promise in reducing cytarabine's harmful effects on organs.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Five FDA-approved drugs may help block COVID-19 virus entry.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

The HCR gene contributes to psoriasis risk.

Cepharanthine shows promise as a COVID-19 treatment.

Topical IKKα inhibitors may help prevent CCS tumours.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Higher CRHR1 levels in AA patients lead to increased inflammation.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Cadd4 effectively reduces cholesterol levels without side effects.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.